The BPCA DCC supports multiple clinical trials involving exclusively infants and children designed to improve labeling of drugs for pediatric use.
The PEAR study is designed to evaluate 800 randomized subjects with a history of hypertension controlled by medication.
PACT provides education, leadership & production assistance to the cell therapy community through contract manufacturing of therapeutic cell products.